A multicenter comparison of MOG-IgG cell-based assays | Neurology
The Mayo Clinic Neuroimmunology Laboratory - The MOG Project
MOG-IgG and AQP4-IgG Testing for Optic Neuritis - Insights
Clues for defining the diagnosis and course of demyelinating diseases - Mayo Clinic
Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview - Fujihara - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody | SpringerLink
Frontiers | Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
PDF) The Mayo Clinic Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders Study: Systematic sero-prevalence of coexisting glial (aquaporin-4), neuronal and other organ and non-organ specific autoantibodies
Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Autoimmunity
The Mayo Clinic Neuroimmunology Laboratory - The MOG Project
International multicenter examination of MOG antibody assays | Neurology Neuroimmunology & Neuroinflammation
MOG-IgG and AQP4-IgG Testing for Optic Neuritis - Insights
Figure Comparison of positive and negative controls for Oxford,... | Download Scientific Diagram
The Mayo Clinic Neuroimmunology Laboratory - The MOG Project
Mog igg mayo clinic - nn-itvn.net
Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis - Mayo Clinic
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Autoimmunity
Mog igg mayo clinic - aimerangers2020.fr
Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis - Ophthalmology
Novel MOG assay aids diagnosis of demyelinating diseases - Mayo Clinic
